Status: Not yet recruiting
Semaglutide (Wegovy) Treatment for Trichotillomania
This research study is testing the effectiveness and safety of semaglutide (Wegovy) in people with trichotillomania, also known as hair-pulling disorder.
Participants needed: 10
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: University of ChicagoUpdated: Jun 10, 2026
Eligibility criteria
Men and women age 18-75; [+4]
Infrequent pulling (i.e. less than daily) or automatic pulling (i.e. no urges to... [+18]